FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’

Agency says application rejected due to lack of adequate and well controlled' trial, but experts say they're just coming up with reasons'

A senior US Food and Drug Administration (FDA) official says Moderna's clinical trial on a new, potentially more effective flu vaccine was a brazen failure" and that the FDA is now calling it into question.

The FDA unexpectedly refused to consider Moderna's application for a flu shot based on messenger RNA (mRNA) technology in a decision that experts say is already having a chilling effect on vaccine development.